138 related articles for article (PubMed ID: 14970244)
1. Immunological detection and cytotoxic properties of toxins from toxin A-positive, toxin B-positive Clostridium difficile variants.
Blake JE; Mitsikosta F; Metcalfe MA
J Med Microbiol; 2004 Mar; 53(Pt 3):197-205. PubMed ID: 14970244
[TBL] [Abstract][Full Text] [Related]
2. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR.
Kato H; Kato N; Watanabe K; Iwai N; Nakamura H; Yamamoto T; Suzuki K; Kim SM; Chong Y; Wasito EB
J Clin Microbiol; 1998 Aug; 36(8):2178-82. PubMed ID: 9665986
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital.
Geric B; Rupnik M; Gerding DN; Grabnar M; Johnson S
J Med Microbiol; 2004 Sep; 53(Pt 9):887-894. PubMed ID: 15314196
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of immunological properties and cytotoxic effects of Clostridium difficile toxin B and Clostridium sordellii toxin L.
Baldacini O; Girardot R; Green GA; Rihn B; Monteil H
Toxicon; 1992 Feb; 30(2):129-40. PubMed ID: 1557784
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
[TBL] [Abstract][Full Text] [Related]
6. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes.
Rupnik M
FEMS Microbiol Rev; 2008 May; 32(3):541-55. PubMed ID: 18397287
[TBL] [Abstract][Full Text] [Related]
8. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia.
Rupnik M; Kato N; Grabnar M; Kato H
J Clin Microbiol; 2003 Mar; 41(3):1118-25. PubMed ID: 12624039
[TBL] [Abstract][Full Text] [Related]
9. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.
Rupnik M; Avesani V; Janc M; von Eichel-Streiber C; Delmée M
J Clin Microbiol; 1998 Aug; 36(8):2240-7. PubMed ID: 9665999
[TBL] [Abstract][Full Text] [Related]
10. How to detect Clostridium difficile variant strains in a routine laboratory.
Rupnik M
Clin Microbiol Infect; 2001 Aug; 7(8):417-20. PubMed ID: 11591204
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting.
Quemeneur L; Petiot N; Arnaud-Barbe N; Hessler C; Pietrobon PJ; Londoño-Hayes P
Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29632249
[No Abstract] [Full Text] [Related]
12. Evaluation of different methods for detection of Clostridium difficile toxins in Poland.
Martirosian G; Pituch H; Obuch-Woszczatyński P; Rouyan G; Meisel-Mikołajczyk F
Acta Microbiol Pol; 1999; 48(4):349-53. PubMed ID: 10756719
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland.
Drudy D; Harnedy N; Fanning S; O'Mahony R; Kyne L
Clin Microbiol Infect; 2007 Mar; 13(3):298-304. PubMed ID: 17391385
[TBL] [Abstract][Full Text] [Related]
14. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.
Warny M; Pepin J; Fang A; Killgore G; Thompson A; Brazier J; Frost E; McDonald LC
Lancet; 2005 Sep 24-30; 366(9491):1079-84. PubMed ID: 16182895
[TBL] [Abstract][Full Text] [Related]
15. Variant forms of the binary toxin CDT locus and tcdC gene in Clostridium difficile strains.
Stare BG; Delmée M; Rupnik M
J Med Microbiol; 2007 Mar; 56(Pt 3):329-335. PubMed ID: 17314362
[TBL] [Abstract][Full Text] [Related]
16. Detection of Clostridium difficile toxin A by reversed passive latex agglutination.
Toma C; Nakamura S; Kamiya S; Nakasone N; Iwanaga M
Microbiol Immunol; 1999; 43(8):737-42. PubMed ID: 10524790
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Clostridium difficile toxinotypes in infected patients at a tertiary care center in Lebanon.
Moukhaiber R; Araj GF; Kissoyan KA; Cheaito KA; Matar GM
J Infect Dev Ctries; 2015 Jul; 9(7):732-5. PubMed ID: 26230123
[TBL] [Abstract][Full Text] [Related]
18. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.
Borriello SP; Barclay FE; Reed PJ; Welch AR; Brown JD; Burdon DW
J Clin Pathol; 1987 May; 40(5):573-80. PubMed ID: 3108333
[TBL] [Abstract][Full Text] [Related]
19. Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro Cd polymerase chain reaction as confirmatory procedures.
Doing KM; Hintz MS; Keefe C; Horne S; LeVasseur S; Kulikowski ML
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):129-34. PubMed ID: 20117349
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
Popoff MR
Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
